HomeSPRO • NASDAQ
add
Spero Therapeutics Inc
Previous close
$0.73
Day range
$0.73 - $0.75
Year range
$0.51 - $1.72
Market cap
40.54M USD
Avg Volume
165.75K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 15.04M | -79.54% |
Operating expense | -58.74M | -122.14% |
Net income | -20.89M | -140.80% |
Net profit margin | -138.85 | -299.41% |
Earnings per share | -0.37 | -138.22% |
EBITDA | -20.85M | -141.23% |
Effective tax rate | -1.41% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 52.89M | -30.71% |
Total assets | 110.54M | -39.39% |
Total liabilities | 64.42M | -14.67% |
Total equity | 46.12M | — |
Shares outstanding | 55.90M | — |
Price to book | 0.86 | — |
Return on assets | -42.42% | — |
Return on capital | -86.47% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -20.89M | -140.80% |
Cash from operations | -23.40M | -33.77% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -23.40M | -33.78% |
Free cash flow | -10.61M | -802.25% |
About
Founded
2013
Website
Employees
32
